RT @JACCJournals: Should hybrid coronary revascuralization with LIMA to LAD and replacement of saphenous vein grafts with drug-eluting sten…
RT @JACCJournals: Should hybrid coronary revascuralization with LIMA to LAD and replacement of saphenous vein grafts with drug-eluting sten…
RT @JACCJournals: Should hybrid coronary revascuralization with LIMA to LAD and replacement of saphenous vein grafts with drug-eluting sten…
Should hybrid coronary revascuralization with LIMA to LAD and replacement of saphenous vein grafts with drug-eluting stents be our new standard for multivessel #cvCAD? Learn with this week's #JACC: https://t.co/jD78EUtBsl @GreggWStone @IcahnMountSinai http
The Hybrid Coronary Approach for Optimal Revascularization https://t.co/cIl2nrbCy3
#Clinicalquestion Why do we still use the SVG? Nice review of the Hybrid Procedure in @JACCJournals https://t.co/UBtL1djkuK https://t.co/YB4IYg3DAY
RT @omendiz: How often do u use it? @mmamas1973 @FaisalBakaeen @DrSheilaSahni @mirvatalasnag @SABOURETCardio @felixdamasds The Hyb…
RT @sabeedak1: #ACCFIT #ACCIC Great piece ! https://t.co/aPW6svPl64 @GonzalezLenguMD @UjjwalRastogiMD @ameeshisath
The Hybrid Coronary Approach for Optimal Revascularization | JACC: Journal of the American College of Cardiology https://t.co/8e1zod0HNq
RT @Susumu_Manabe: ハイブリッドの血行再建が、総説としてJACCで紹介されている.左胸の小さな傷からロボットで内胸動脈をとって左前下行枝にバイパス、残りはPCIで血行再建.https://t.co/yTYPzd0IFI https://t.co/8tjOOHf…
開胸せずにバイパスできるのなら、すごい。
The Annals of Cardiovascular and Thoracic Surgery journal# Research#submit#Manuscript#online submission# https://t.co/VbGiad0iSe
The Annals of Cardiovascular and Thoracic Surgery journal# Research#submit#Manuscript#online submission# https://t.co/VbGiad0iSe
In a young pt whose surgery risk is low, complete arterial revascularization would seem the more durable option than LIMA and stents. W/ hybrid, reop for in-stent stenosis now more complex w/ patent LIMA to LAD. Why compromise a definitive operation when
RT @sabeedak1: #ACCFIT #ACCIC Great piece ! https://t.co/aPW6svPl64 @GonzalezLenguMD @UjjwalRastogiMD @ameeshisath
#ACCFIT #ACCIC Great piece ! https://t.co/aPW6svPl64 @GonzalezLenguMD @UjjwalRastogiMD @ameeshisath
RT @omendiz: How often do u use it? @mmamas1973 @FaisalBakaeen @DrSheilaSahni @mirvatalasnag @SABOURETCardio @felixdamasds The Hyb…
RT @Susumu_Manabe: ハイブリッドの血行再建が、総説としてJACCで紹介されている.左胸の小さな傷からロボットで内胸動脈をとって左前下行枝にバイパス、残りはPCIで血行再建.https://t.co/yTYPzd0IFI https://t.co/8tjOOHf…
RT @Susumu_Manabe: ハイブリッドの血行再建が、総説としてJACCで紹介されている.左胸の小さな傷からロボットで内胸動脈をとって左前下行枝にバイパス、残りはPCIで血行再建.https://t.co/yTYPzd0IFI https://t.co/8tjOOHf…
ハイブリッドの血行再建が、総説としてJACCで紹介されている.左胸の小さな傷からロボットで内胸動脈をとって左前下行枝にバイパス、残りはPCIで血行再建.https://t.co/yTYPzd0IFI https://t.co/8tjOOHfa8m
RT @omendiz: How often do u use it? @mmamas1973 @FaisalBakaeen @DrSheilaSahni @mirvatalasnag @SABOURETCardio @felixdamasds The Hyb…
RT @omendiz: How often do u use it? @mmamas1973 @FaisalBakaeen @DrSheilaSahni @mirvatalasnag @SABOURETCardio @felixdamasds The Hyb…
#ACCIC #EAPCI We’re use it without the evidence (minimally invasive CAB) Sadly #HybridTrial @GreggWStone stopped due to recruitment issues https://t.co/5iF1pyuen0 @TCTMD @ToddNeale
RT @omendiz: How often do u use it? @mmamas1973 @FaisalBakaeen @DrSheilaSahni @mirvatalasnag @SABOURETCardio @felixdamasds The Hyb…
How often do u use it? @mmamas1973 @FaisalBakaeen @DrSheilaSahni @mirvatalasnag @SABOURETCardio @felixdamasds The Hybrid Coronary Approach for Optimal Revascularization|JACC: Journal of the American College of Cardiology https://t.co/bkPZ3dK6bV